1 | 150 mg double-blinded secukinumab (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 |
2 | 150 mg open-label secukinumab (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 |
3 | 300 mg double-blinded secukinumab (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 |
4 | Cosentyx | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 4件: 41 41, 107, 269, 271 |
5 | COSENTYX - 150 MG - SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA -USO SOTTOCUTANEO - SIRINGA (VETRO) 1 ML (150MG/ML)- 1 SIRINGA PRERIEMPITA | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 107 107 |
6 | COSENTYX - 150 MG - SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA -USO SOTTOCUTANEO - SIRINGA (VETRO) 1 ML (150MG/ML)- 2 SIRINGHE PRERIEMPITE | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 107 107 |
7 | Cosentyx 300 mg solution for injection in pre-filled syringe | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 |
8 | Cosentyx 300mg solution for injection in pre-filled syringe | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 |
9 | Cosentyx® | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 269 269 |
10 | SECUKINUMAB (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 8件: 13 13, 37, 41, 46, 107, 160, 269, 271 |
11 | Secukinumab (150 mg) (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 |
12 | Secukinumab (75 mg) (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 |
13 | Secukinumab (AIN457) (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 46 46 |
14 | Secukinumab (AIN457) 150 mg s.c. (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 |
15 | Secukinumab 150 mg (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 |
16 | Secukinumab 150 mg (2 injections per dose (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 269 269 |
17 | Secukinumab 150 mg provided in 1.0 mL pre-filled syringes (PFSs) for sc injection. (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 |
18 | Secukinumab 150 mg/1 mL Solution for injection (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 2件: 37 37, 271 |
19 | Secukinumab 150 mg/ml (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 |
20 | Secukinumab 150 milligram [Cosentyx] | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 |
21 | Secukinumab 150mg (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 37 37 |
22 | Secukinumab 300 mg (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 |
23 | Secukinumab 300 mg, s.c. (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 |
24 | Secukinumab 300mg (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 37 37 |
25 | Secukinumab 75 mg/0.5 ml Solution for injection (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 |
26 | Secukinumab Injection (Synonym: Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Synonym: Cosentyx) | 1件: D09967
D09967
(Name: Cosentyx (TN)) | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 160 160 |